BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35705526)

  • 1. MAB21L4 Deficiency Drives Squamous Cell Carcinoma via Activation of RET.
    Srivastava A; Tommasi C; Sessions D; Mah A; Bencomo T; Garcia JM; Jiang T; Lee M; Shen JY; Seow LW; Nguyen A; Rajapakshe K; Coarfa C; Tsai KY; Lopez-Pajares V; Lee CS
    Cancer Res; 2022 Sep; 82(17):3143-3157. PubMed ID: 35705526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survivin Modulates Squamous Cell Carcinoma-Derived Stem-Like Cell Proliferation, Viability and Tumor Formation in Vivo.
    Lotti R; Palazzo E; Petrachi T; Dallaglio K; Saltari A; Truzzi F; Quadri M; Puviani M; Maiorana A; Marconi A; Pincelli C
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26771605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vandetanib inhibits cell growth in EGFR-expressing cutaneous squamous cell carcinoma.
    Kitamura S; Maeda T; Yanagi T
    Biochem Biophys Res Commun; 2020 Oct; 531(3):396-401. PubMed ID: 32800552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-181a decelerates proliferation in cutaneous squamous cell carcinoma by targeting the proto-oncogene KRAS.
    Neu J; Dziunycz PJ; Dzung A; Lefort K; Falke M; Denzler R; Freiberger SN; Iotzova-Weiss G; Kuzmanov A; Levesque MP; Dotto GP; Hofbauer GFL
    PLoS One; 2017; 12(9):e0185028. PubMed ID: 28931048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro.
    Cheung BB; Koach J; Tan O; Kim P; Bell JL; D'andreti C; Sutton S; Malyukova A; Sekyere E; Norris M; Haber M; Kavallaris M; Cunningham AM; Proby C; Leigh I; Wilmott JS; Cooper CL; Halliday GM; Scolyer RA; Marshall GM
    J Pathol; 2012 Feb; 226(3):451-62. PubMed ID: 22009481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keratinocyte growth factor induces gene expression signature associated with suppression of malignant phenotype of cutaneous squamous carcinoma cells.
    Toriseva M; Ala-aho R; Peltonen S; Peltonen J; Grénman R; Kähäri VM
    PLoS One; 2012; 7(3):e33041. PubMed ID: 22427941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAB21L4 regulates the TGF-β-induced expression of target genes in epidermal keratinocytes.
    Ogami T; Tamura Y; Toss K; Yuki K; Morikawa M; Tsutsumi S; Aburatani H; Miyazawa K; Miyazono K; Koinuma D
    J Biochem; 2022 Mar; 171(4):399-410. PubMed ID: 34908107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
    Bowden GT; Schneider B; Domann R; Kulesz-Martin M
    Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel initiation genes in squamous cell carcinomagenesis: a role for substrate-specific ubiquitylation in the control of cell survival.
    Albor A; Kulesz-Martin M
    Mol Carcinog; 2007 Aug; 46(8):585-90. PubMed ID: 17626251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Rab25 promotes the development of skin squamous cell carcinoma through the dysregulation of integrin trafficking.
    Jeong H; Lim KM; Kim KH; Cho Y; Lee B; Knowles BC; Roland JT; Zwerner JP; Goldenring JR; Nam KT
    J Pathol; 2019 Oct; 249(2):227-240. PubMed ID: 31144312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plexin-B1 and semaphorin 4D cooperate to promote cutaneous squamous cell carcinoma cell proliferation, migration and invasion.
    Cao J; Zhang C; Chen T; Tian R; Sun S; Yu X; Xiao C; Wang G; Liu Y; Fu M; Li W
    J Dermatol Sci; 2015 Aug; 79(2):127-36. PubMed ID: 26051877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.
    Nissinen L; Farshchian M; Riihilä P; Kähäri VM
    Cell Tissue Res; 2016 Sep; 365(3):691-702. PubMed ID: 27411692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro three-dimensional model of primary human cutaneous squamous cell carcinoma.
    Commandeur S; de Gruijl FR; Willemze R; Tensen CP; El Ghalbzouri A
    Exp Dermatol; 2009 Oct; 18(10):849-56. PubMed ID: 19469895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twist1 is required for the development of UVB-induced squamous cell carcinoma.
    Eguiarte-Solomon F; Blazanin N; Rho O; Carbajal S; Felsher DW; Tran PT; DiGiovanni J
    Mol Carcinog; 2021 May; 60(5):342-353. PubMed ID: 33713497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary tumor-transforming gene 1 as a proliferation marker lacking prognostic value in cutaneous squamous cell carcinoma.
    Ishitsuka Y; Kawachi Y; Taguchi S; Maruyama H; Nakamura Y; Fujisawa Y; Furuta J; Nakamura Y; Ishii Y; Otsuka F
    Exp Dermatol; 2013 May; 22(5):318-22. PubMed ID: 23489647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALK, ROS1 and RET rearrangements in lung squamous cell carcinoma are very rare.
    Zhao W; Choi YL; Song JY; Zhu Y; Xu Q; Zhang F; Jiang L; Cheng J; Zheng G; Mao M
    Lung Cancer; 2016 Apr; 94():22-7. PubMed ID: 26973202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible Roles of Proinflammatory Signaling in Keratinocytes Through Aryl Hydrocarbon Receptor Ligands for the Development of Squamous Cell Carcinoma.
    Sato Y; Fujimura T; Hidaka T; Lyu C; Tanita K; Matsushita S; Yamamoto M; Aiba S
    Front Immunol; 2020; 11():534323. PubMed ID: 33178182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes.
    Li L; Li F; Xia Y; Yang X; Lv Q; Fang F; Wang Q; Bu W; Wang Y; Zhang K; Wu Y; Shen J; Jiang M
    EBioMedicine; 2020 Jul; 57():102835. PubMed ID: 32574963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inefficient differentiation response to cell cycle stress leads to genomic instability and malignant progression of squamous carcinoma cells.
    Alonso-Lecue P; de Pedro I; Coulon V; Molinuevo R; Lorz C; Segrelles C; Ceballos L; López-Aventín D; García-Valtuille A; Bernal JM; Mazorra F; Pujol RM; Paramio J; Ramón Sanz J; Freije A; Toll A; Gandarillas A
    Cell Death Dis; 2017 Jun; 8(6):e2901. PubMed ID: 28661481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and induces tumorigenic properties.
    Hoesl C; Zanuttigh E; Fröhlich T; Philippou-Massier J; Krebs S; Blum H; Dahlhoff M
    Biochim Biophys Acta Mol Cell Res; 2020 Aug; 1867(8):118717. PubMed ID: 32283126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.